IGHE and congenital rubella syndrome: CRS patients were stratified according to markers of type 2 inflammation (Table 1): BEC (< 150 cells/μL: 21.6% of patients, ≥ 150 cells/μL: 78.4%; < 250 cells/μL: 36.3%, ≥ 250 cells/μL: 63.7%), serum total IgE (< 100 IU/mL: 59.9%, ≥ 100 IU/mL: 40.1%).